202410261801
Status:
Tags: pharmacology, Obstetrics
Atosiban
competitive antagonist for oxytocin receptors
can be prescribed as low dose (~100µg/min) or high dose (~300µg/min) infusions
possible ADR:
- nausea / vomiting
- dizziness
- hot flushes
- tachcardia
- hypotension
- hyperglycaemia
- injection site reactions